Science Translational Medicine,
Год журнала:
2023,
Номер
15(700)
Опубликована: Июнь 14, 2023
Alzheimer’s
disease
(AD)
pathology
is
thought
to
progress
from
normal
cognition
through
preclinical
and
ultimately
symptomatic
AD
with
cognitive
impairment.
Recent
work
suggests
that
the
gut
microbiome
of
patients
has
an
altered
taxonomic
composition
compared
healthy,
cognitively
control
individuals.
However,
knowledge
about
changes
in
before
onset
limited.
In
this
cross-sectional
study
accounted
for
clinical
covariates
dietary
intake,
we
microbial
function
a
cohort
164
individuals,
49
whom
showed
biomarker
evidence
early
AD.
Gut
profiles
individuals
were
distinct
those
without
The
change
correlated
β-amyloid
(Aβ)
tau
pathological
biomarkers
but
not
neurodegeneration,
suggesting
may
process.
We
identified
specific
bacterial
taxa
associated
Inclusion
these
features
improved
accuracy,
sensitivity,
specificity
machine
learning
classifiers
predicting
status
when
tested
on
subset
(65
participants).
correlates
neuropathology
improve
our
understanding
etiology
help
identify
gut-derived
markers
risk.
Cell Research,
Год журнала:
2019,
Номер
29(10), С. 787 - 803
Опубликована: Сен. 6, 2019
Recently,
increasing
evidence
has
suggested
the
association
between
gut
dysbiosis
and
Alzheimer's
disease
(AD)
progression,
yet
role
of
microbiota
in
AD
pathogenesis
remains
obscure.
Herein,
we
provide
a
potential
mechanistic
link
neuroinflammation
progression.
Using
mouse
models,
discovered
that,
during
alteration
composition
leads
to
peripheral
accumulation
phenylalanine
isoleucine,
which
stimulates
differentiation
proliferation
pro-inflammatory
T
helper
1
(Th1)
cells.
The
brain-infiltrated
Th1
immune
cells
are
associated
with
M1
microglia
activation,
contributing
AD-associated
neuroinflammation.
Importantly,
elevation
isoleucine
concentrations
increase
cell
frequency
blood
were
also
observed
two
small
independent
cohorts
patients
mild
cognitive
impairment
(MCI)
due
AD.
Furthermore,
GV-971,
sodium
oligomannate
that
demonstrated
solid
consistent
cognition
improvement
phase
3
clinical
trial
China,
suppresses
phenylalanine/isoleucine
accumulation,
harnesses
reverses
impairment.
Together,
our
findings
highlight
dysbiosis-promoted
progression
suggest
novel
strategy
for
therapy
by
remodelling
microbiota.
Signal Transduction and Targeted Therapy,
Год журнала:
2022,
Номер
7(1)
Опубликована: Дек. 16, 2022
Aging
is
a
gradual
and
irreversible
pathophysiological
process.
It
presents
with
declines
in
tissue
cell
functions
significant
increases
the
risks
of
various
aging-related
diseases,
including
neurodegenerative
cardiovascular
metabolic
musculoskeletal
immune
system
diseases.
Although
development
modern
medicine
has
promoted
human
health
greatly
extended
life
expectancy,
aging
society,
variety
chronic
diseases
have
gradually
become
most
important
causes
disability
death
elderly
individuals.
Current
research
on
focuses
elucidating
how
endogenous
exogenous
stresses
(such
as
genomic
instability,
telomere
dysfunction,
epigenetic
alterations,
loss
proteostasis,
compromise
autophagy,
mitochondrial
cellular
senescence,
stem
exhaustion,
altered
intercellular
communication,
deregulated
nutrient
sensing)
participate
regulation
aging.
Furthermore,
thorough
pathogenesis
to
identify
interventions
that
promote
longevity
caloric
restriction,
microbiota
transplantation,
nutritional
intervention)
clinical
treatment
methods
for
(depletion
senescent
cells,
therapy,
antioxidative
anti-inflammatory
treatments,
hormone
replacement
therapy)
could
decrease
incidence
turn
healthy
longevity.
Current Nutrition Reports,
Год журнала:
2019,
Номер
8(2), С. 53 - 65
Опубликована: Апрель 4, 2019
Nutrition
is
known
to
modulate
the
immune
system
and
may
alter
neuroinflammatory
processes
implicated
in
pathogenesis
of
Alzheimer's
disease
(AD)
progression
neurodegeneration.
Here,
we
review
evidence
for
healthy
dietary
patterns
age-related
cognition
discuss
potential
actions
diet
on
cognitive
function.
Anti-inflammatory
such
as
Mediterranean
(MD)
approaches
stop
hypertension
(DASH)
be
neuroprotective.
Several
components
consumed
MD
DASH
(omega-3
fatty
acids,
antioxidants
polyphenols)
can
inhibit
neuroinflammation
associated
with
AD.
diets
also
attenuate
via
indirect
pathways
from
gut
microbiome
systemic
circulation.
Diet
influence
ageing
several
inflammatory
pathways.
However,
data
human
studies
are
lacking
exact
mechanisms
linking
function
remain
elusive.
Further
intervention
required
investigate
diet-associated
neurological
change
earliest
through
latest
stages
decline.
Furthermore,
incorporation
neuroimaging
measures
would
advance
current
understanding
mechanistic
effects
modification
brain.
Ageing Research Reviews,
Год журнала:
2021,
Номер
70, С. 101397 - 101397
Опубликована: Июнь 30, 2021
An
excess
of
saturated
fatty
acids
and
simple
sugars
in
the
diet
is
a
known
environmental
risk
factor
Alzheimer's
disease
(AD)
but
holistic
view
interacting
processes
through
which
such
may
contribute
to
AD
pathogenesis
missing.
We
addressed
this
need
extensive
analysis
published
studies
investigating
effects
western
(WD)
on
development
humans
laboratory
animals.
reviewed
WD-induced
systemic
alterations
comprising
metabolic
changes,
induction
obesity
adipose
tissue
inflammation,
gut
microbiota
dysbiosis
acceleration
low-grade
inflammation.
Next
we
provide
an
overview
evidence
demonstrating
that
WD-associated
drive
impairment
blood-brain
barrier
(BBB)
neuroinflammation
paralleled
by
accumulation
toxic
amyloid.
Later
these
changes
are
followed
dysfunction
synaptic
transmission,
neurodegeneration
finally
memory
cognitive
impairment.
conclude
WD
can
trigger
inflammaging,
BBB
induced
inflammation
play
central
role
process.
Moreover,
concurrence
Aβ
dyshomeostasis,
reciprocal
interactions
vicious
cycle
neurodegeneration,
contradicts
as
primary
AD.
Given
2019
World
Health
Organization
recommended
focusing
modifiable
factors
prevention,
sequential,
complex
pathomechanisms
initiated
WD,
lead
from
peripheral
disturbances
support
future
prevention
strategies.
Nutrients,
Год журнала:
2020,
Номер
13(1), С. 37 - 37
Опубликована: Дек. 24, 2020
For
years,
it
has
been
reported
that
Alzheimer’s
disease
(AD)
is
the
most
common
cause
of
dementia.
Various
external
and
internal
factors
may
contribute
to
early
onset
AD.
This
review
highlights
a
contribution
disturbances
in
microbiota–gut–brain
(MGB)
axis
development
Alteration
gut
microbiota
composition
determined
by
increase
permeability
barrier
immune
cell
activation,
leading
impairment
blood–brain
function
promotes
neuroinflammation,
neuronal
loss,
neural
injury,
ultimately
Numerous
studies
have
shown
plays
crucial
role
brain
changes
behavior
individuals
formation
bacterial
amyloids.
Lipopolysaccharides
amyloids
synthesized
can
trigger
cells
residing
activate
response
neuroinflammation.
Growing
experimental
clinical
data
indicate
prominent
dysbiosis
microbiota–host
interactions
Modulation
with
antibiotics
or
probiotic
supplementation
create
new
preventive
therapeutic
options
Accumulating
evidences
affirm
research
on
MGB
involvement
AD
necessary
for
treatment
targets
therapies
Physiological Reviews,
Год журнала:
2021,
Номер
101(3), С. 1047 - 1081
Опубликована: Янв. 21, 2021
The
history
of
Alzheimer's
disease
(AD)
started
in
1907,
but
we
needed
to
wait
until
the
end
century
identify
components
pathological
hallmarks
and
genetic
subtypes
formulate
first
pathogenic
hypothesis.
Thanks
biomarkers
new
technologies,
concept
AD
then
rapidly
changed
from
a
static
view
an
amnestic
dementia
presenium
biological
entity
that
could
be
clinically
manifested
as
normal
cognition
or
different
types.
What
is
clearly
emerging
studies
heterogeneous
each
aspect,
such
amyloid
composition,
tau
distribution,
relation
between
tau,
clinical
symptoms,
background,
thus
it
probably
impossible
explain
with
single
process.
scientific
approach
suffers
chronological
mismatches
clinical,
pathological,
technological
data,
causing
difficulty
conceiving
diagnostic
gold
standards
creating
models
for
drug
discovery
screening.
A
recent
mathematical
computer-based
offers
opportunity
study
real
life
provide
point
final
missing
pieces
puzzle.
Molecular Neurodegeneration,
Год журнала:
2022,
Номер
17(1)
Опубликована: Март 5, 2022
The
implication
of
gut
microbiota
in
the
control
brain
functions
health
and
disease
is
a
novel,
currently
emerging
concept.
Accumulating
data
suggest
that
exert
its
action
at
least
part
by
modulating
neuroinflammation.
Given
link
between
neuroinflammatory
changes
neuronal
activity,
it
plausible
may
affect
indirectly
impacting
microglia,
key
player
Indeed,
increasing
evidence
suggests
interplay
microglia
synaptic
dysfunction
involve
microbiota,
among
other
factors.
In
addition
to
these
indirect
microglia-dependent
actions
on
has
been
recently
recognized
could
also
activity
directly
stimulation
vagus
nerve.